27555478|t|Activation of the Na(+)/H(+) exchanger in isolated cardiomyocytes through β-Raf dependent pathways. Role of Thr(653) of the cytosolic tail
27555478|a|The mammalian Na(+)/H(+) exchanger isoform 1 (NHE1) is a ubiquitous plasma membrane protein that is a key regulator of intracellular pH in isolated cardiomyocytes. A 500 amino acid membrane domain removes protons and is regulated by a 315 amino acid cytosolic domain. In the myocardium, aberrant regulation of NHE1 contributes to ischemia reperfusion damage and to heart hypertrophy. We examined mechanisms of regulation of NHE1 in the myocardium by endothelin and β-Raf. Endothelin stimulated NHE1 activity and activated Erk-dependent pathways. Inhibition of β-Raf reduced NHE1 activity and Erk-pathway activation. We demonstrated that myocardial β-Raf binds to the C-terminal 182 amino acids of the NHE1 protein and that β-Raf is associated with NHE1 in intact cardiomyocytes. NHE1 was phosphorylated in vivo and the protein kinase inhibitor sorafenib reduced NHE1 phosphorylation levels. Immunoprecipitates of β-Raf from cardiomyocytes phosphorylated the C-terminal 182 amino acids of NHE1 and mass spectrometry analysis showed that amino acid Thr(653) was phosphorylated. Mutation of this amino acid to Ala resulted in defective activity while mutation to Asp restored the activity. The results demonstrate that Thr(653) is an important regulator y amino acid of NHE1 that is activated through β-Raf dependent pathways by phosphorylation either directly or indirectly by β-Raf, and this affects NHE1 activity.
27555478	0	10	Activation	T052	C1879547
27555478	18	38	Na(+)/H(+) exchanger	T116,T123	C0074785
27555478	42	50	isolated	T169	C0205409
27555478	51	65	cardiomyocytes	T025	C0225828
27555478	74	79	β-Raf	T116,T123	C1259929
27555478	90	98	pathways	T044	C1704259
27555478	108	116	Thr(653)	T116,T121,T123	C0040005
27555478	124	138	cytosolic tail	T026	C1511625
27555478	143	152	mammalian	T015	C0024660
27555478	153	183	Na(+)/H(+) exchanger isoform 1	T116,T123	C1113671
27555478	185	189	NHE1	T116,T123	C1113671
27555478	207	230	plasma membrane protein	T116,T123	C1179841
27555478	245	274	regulator of intracellular pH	T040	C1655052
27555478	278	286	isolated	T169	C0205409
27555478	287	301	cardiomyocytes	T025	C0225828
27555478	309	335	amino acid membrane domain	T087	C1513110
27555478	344	351	protons	T196	C0033727
27555478	378	388	amino acid	T116,T121,T123	C0002520
27555478	389	405	cytosolic domain	T026	C1511625
27555478	414	424	myocardium	T024	C0027061
27555478	426	434	aberrant	T080	C0443127
27555478	435	445	regulation	T038	C1327622
27555478	449	453	NHE1	T116,T123	C1113671
27555478	469	496	ischemia reperfusion damage	T037	C0035126
27555478	504	521	heart hypertrophy	T046	C1383860
27555478	526	534	examined	T033	C0332128
27555478	535	545	mechanisms	T169	C0441712
27555478	549	559	regulation	T038	C1327622
27555478	563	567	NHE1	T116,T123	C1113671
27555478	575	585	myocardium	T024	C0027061
27555478	589	599	endothelin	T116,T123	C0079284
27555478	604	609	β-Raf	T116,T123	C1259929
27555478	611	621	Endothelin	T116,T123	C0079284
27555478	633	637	NHE1	T116,T123	C1113671
27555478	638	646	activity	T052	C0441655
27555478	651	660	activated	T052	C1879547
27555478	661	683	Erk-dependent pathways	T044	C3179234
27555478	699	704	β-Raf	T116,T123	C1259929
27555478	713	717	NHE1	T116,T123	C1113671
27555478	718	726	activity	T052	C0441655
27555478	731	742	Erk-pathway	T044	C3179234
27555478	743	753	activation	T052	C1879547
27555478	776	786	myocardial	T024	C0027061
27555478	787	792	β-Raf	T116,T123	C1259929
27555478	793	798	binds	T052	C1145667
27555478	806	832	C-terminal 182 amino acids	T087	C1707271
27555478	840	852	NHE1 protein	T116,T123	C1113671
27555478	862	867	β-Raf	T116,T123	C1259929
27555478	871	886	associated with	T080	C0332281
27555478	887	891	NHE1	T116,T123	C1113671
27555478	895	901	intact	T080	C0205266
27555478	902	916	cardiomyocytes	T025	C0225828
27555478	918	922	NHE1	T116,T123	C1113671
27555478	927	941	phosphorylated	T044	C0031715
27555478	942	949	in vivo	T082	C1515655
27555478	958	982	protein kinase inhibitor	T116,T121	C1449702
27555478	983	992	sorafenib	T109,T121	C1516119
27555478	1001	1005	NHE1	T116,T123	C1113671
27555478	1006	1021	phosphorylation	T044	C0031715
27555478	1030	1048	Immunoprecipitates	T129	C0301871
27555478	1052	1057	β-Raf	T116,T123	C1259929
27555478	1063	1077	cardiomyocytes	T025	C0225828
27555478	1078	1092	phosphorylated	T044	C0031715
27555478	1097	1123	C-terminal 182 amino acids	T087	C1707271
27555478	1127	1131	NHE1	T116,T123	C1113671
27555478	1136	1162	mass spectrometry analysis	T059	C0037813
27555478	1175	1185	amino acid	T116,T121,T123	C0002520
27555478	1186	1194	Thr(653)	T116,T121,T123	C0040005
27555478	1199	1213	phosphorylated	T044	C0031715
27555478	1215	1223	Mutation	T045	C0026882
27555478	1232	1242	amino acid	T116,T121,T123	C0002520
27555478	1246	1249	Ala	T116,T123	C0001898
27555478	1262	1271	defective	T169	C0332452
27555478	1272	1280	activity	T052	C0441655
27555478	1287	1295	mutation	T045	C0026882
27555478	1299	1302	Asp	T116,T123	C0085845
27555478	1316	1324	activity	T052	C0441655
27555478	1330	1337	results	T034	C0456984
27555478	1355	1363	Thr(653)	T116,T121,T123	C0040005
27555478	1380	1389	regulator	T077	C1704735
27555478	1392	1402	amino acid	T116,T121,T123	C0002520
27555478	1406	1410	NHE1	T116,T123	C1113671
27555478	1419	1428	activated	T052	C1879547
27555478	1437	1442	β-Raf	T116,T123	C1259929
27555478	1453	1461	pathways	T044	C1704259
27555478	1465	1480	phosphorylation	T044	C0031715
27555478	1514	1519	β-Raf	T116,T123	C1259929
27555478	1538	1542	NHE1	T116,T123	C1113671
27555478	1543	1551	activity	T052	C0441655